Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00943813 · ClinicalTrials.gov registry record

Assessment of Comskil Training Through Videorecording and Patient Surveys

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
55
Enrollment target

NCT00943813: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00943813 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00943813 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
55 participants
Enrollment target

Study Summary

At Memorial Sloan-Kettering Cancer Center the investigators want to provide the best care to their patients. One way to do this is to evaluate the ways that doctors communicate with patients. To this end, the Department of Psychiatry and Behavioral Sciences runs a Communication Skills Training and Research Laboratory. One goal of this laboratory is to evaluate doctor-patient communication and provide training in how to improve the quality of this communication. Invitation to participate in this pilot project does not mean that a problem with communication has been identified in your doctor's practice. Rather, it is because your doctor and the fellow working with your doctor have agreed to cooperate with us as the investigators develop strategies to train physicians, nurses and other clinical personnel to communicate with cancer patients in as effective and sensitive a manner as possible.

Interventions

  • BEHAVIORAL video-recording and completing a survey

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2009-05
Est. Completion 2016-08
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00943813 record still lists

NCT00943813 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which video-recording and completing a survey is the first listed.

NCT00943813 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00943813 about?

NCT00943813 is a clinical study titled "Assessment of Comskil Training Through Videorecording and Patient Surveys". At Memorial Sloan-Kettering Cancer Center the investigators want to provide the best care to their patients. One way to do this is to evaluate the ways that doctors communicate with patients. To this end, the Department of Psychiatry and Behavioral Sciences runs a Communication Skills Training and R...

What is the current status of trial NCT00943813?

This trial is currently completed. The enrollment target is 55 participants. The study started on 2009-05. Estimated completion is 2016-08.

What interventions are being tested in trial NCT00943813?

The interventions under investigation include: video-recording and completing a survey (BEHAVIORAL).

Who is sponsoring clinical trial NCT00943813?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01638676 · 55 participants · Phase 1

    A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

  • NCT01906385 · 55 participants · Phase 1

    Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • NCT03007030 · 55 participants · Phase 2

    Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

  • NCT03152058 · 55 participants · Phase 2

    IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00943813, the US trial registry maintained by the National Library of Medicine. NCT00943813 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.